Skip to Content
Merck
  • Inhibition of biofilm formation and antibacterial properties of a silver nano-coating on human dentine.

Inhibition of biofilm formation and antibacterial properties of a silver nano-coating on human dentine.

Nanotoxicology (2013-07-24)
Alexandros Besinis, Tracy De Peralta, Richard D Handy
ABSTRACT

The survival of pathogenic bacteria in the oral cavity depends on their successful adhesion to dental surfaces and their ability to develop into biofilms, known as dental plaque. Bacteria from the dental plaque are responsible for the development of dental caries, gingivitis, periodontitis, stomatitis and peri-implantitis. Certain metal nanoparticles have been suggested for infection control and the management of the oral biofilm. Here, it is shown that application of a silver nano-coating directly on dentine can successfully prevent the biofilm formation on dentine surfaces as well as inhibit bacterial growth in the surrounding media. This silver nano-coating was found to be stable (>98.8%) and to maintain its integrity in biological fluids. Its antibacterial activity was compared to silver nitrate and the widely used clinical antiseptic, chlorhexidine. The bacterial growth and cell viability were quantitatively assessed by measuring the turbidity, proportion of live and dead cells and lactate production. All three bioassays showed that silver nanoparticles and silver nitrate dentine coatings were equally highly bactericidal (>99.5%), while inhibiting bacterial adhesion. However, the latter caused significant dentine discolouration (ΔE* = 50.3). The chlorhexidine coating showed no antibacterial effect. Thus, silver nanoparticles may be a viable alternative to both chlorhexidine and silver nitrate, protecting from dental plaque and secondary caries when applied as a dentine coating, while they may provide the platform for creating anti-biofilm surfaces in medical devices and other biomedical applications.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Silver nanowires, diam. × L 100 nm × 6 μm, 0.5% (isopropyl alcohol suspension)
Sigma-Aldrich
Silver nanowires, diam. × L 50 nm × 6 μm, 0.5% (isopropyl alcohol suspension)
Sigma-Aldrich
Silver, colloidal, 65-75% Ag basis
Sigma-Aldrich
Silver, wire, diam. 0.1 mm, 99.9% trace metals basis
Sigma-Aldrich
Silver, nanopowder, <150 nm particle size, 99% trace metals basis
Sigma-Aldrich
Silver, foil, thickness 1.5 mm, 99.9% trace metals basis
Sigma-Aldrich
Silver, shot, 1-3 mm, ≥99.99% trace metals basis
Sigma-Aldrich
Silver, foil, thickness 1.0 mm, 99.99% trace metals basis
Sigma-Aldrich
Silver nanowires, diam. × L 200  nm × 10 μm, 0.5% (isopropyl alcohol suspension)
Sigma-Aldrich
Silver, conductive paste
Sigma-Aldrich
Silver, flakes, 10 μm, ≥99.9% trace metals basis
Sigma-Aldrich
Silver, foil, thickness 1.0 mm, 99.9% trace metals basis
Sigma-Aldrich
Silver, foil, thickness 0.5 mm, 99.9% trace metals basis
Sigma-Aldrich
Silver, powder, 2-3.5 μm, ≥99.9% trace metals basis
Sigma-Aldrich
Silver, rod, diam. 3.2 mm, 99.98% trace metals basis
Sigma-Aldrich
Silver, wire, diam. 1.5 mm, ≥99.99% trace metals basis
Sigma-Aldrich
Silver, powder, <45 μm, ≥99.99% trace metals basis
Sigma-Aldrich
Silver, powder, 5-8 μm, ≥99.9% trace metals basis
Sigma-Aldrich
Silver, nanopowder, <100 nm particle size, contains PVP as dispersant, 99.5% trace metals basis
Sigma-Aldrich
Silver, evaporation slug, diam. × L 0.6 cm × 1.2 cm, 99.99% trace metals basis
Sigma-Aldrich
Chlorhexidine dihydrochloride, ≥98%
Chlorhexidine dihydrochloride, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Chlorhexidine, ≥99.5%
Chlorhexidine, European Pharmacopoeia (EP) Reference Standard
Silver, wire reel, 5m, diameter 0.5mm, annealed, 99.99%
Supelco
Chlorhexidine, Pharmaceutical Secondary Standard; Certified Reference Material
Silver, wire reel, 1m, diameter 0.5mm, annealed, 99.99%